Cambridge Healthtech Institute第3届

Immuno-Oncology Biomarkers 2: Predictive Biomarkers and Companion Diagnostics

( 癌症免疫疗法的生物标记2:预测生物标记与伴随式诊断 )

2018年8月28日~29日

本单元以对应癌症免疫疗法的预测生物标记与伴随式诊断为主题,制药公司及研究机关中从事生物标记研究的专家将齐聚一堂,针对癌症免疫疗法的预测生物标记及预后生物标记的快速开发、生物标记在临床试验的使用、伴随式诊断的可能性等议题进行讨论。

Coverage will include, but is not limited to:

  • Integrative biomarker analysis from immunology, oncology and "omics" data
  • Immune-based biomarkers to predict clinical response
  • Profiling of tumor infiltrating immune cells
  • Microsatellite instability and mismatch repair deficiency biomarkers
  • Biology of tumor microenvironment
  • PD-L1 as a predictive biomarker and companion diagnostic
  • Mechanism of non-response: resistance or lack of efficacy
  • Development of companion diagnostics assays
  • Regulatory considerations in IO biomarker development

* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English





免费电子邮件通知服务